FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients

Anke Neustadt

Posoleucel’s third RMAT designation marks an unprecedented regulatory distinction among cell and gene therapies Global Phase 3 multi-virus prevention trial initiated in March 2022 and is enrolling patients WALTHAM, Mass., April 20, 2022–(BUSINESS WIRE)–AlloVir (Nasdaq: ALVR), a late clinical-stage allogeneic T cell immunotherapy company, today announced that the U.S. Food […]

A ‘scary man,’ or someone like your uncle? Mass. requires doctors to undergo implicit bias training in an effort to address health care inequities.

Anke Neustadt

Starting June 1, the Board of Registration in Medicine, which licenses doctors in Massachusetts, is requiring all doctors to take two hours of instruction in implicit bias — mistaken beliefs and prejudices that people hold without realizing it. The training will focus on attitudes toward gender, race, ethnicity, and culture. […]